The latest financial statement is for the quarter ending 2025-09-30.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net income (loss) | 56,639 | 3,239 |
| Depreciation and amortization | 49,181 | 83,055 |
| Other amortization | 9,540 | 19,213 |
| Deferred rent | -730 | -1,556 |
| Stock based compensation | 3,429 | 5,741 |
| Loss (gain) on dispositions of real estate investments, net | 691 | -3,035 |
| Impairment of real estate investments | 3,768 | 34,365 |
| Loss from unconsolidated entities | 462 | -3,086 |
| Deferred income taxes | -21,401 | - |
| Gain on re-measurement of previously held equity interest | 14,580 | - |
| Foreign currency gain | -978 | 4,172 |
| Loss on extinguishments of debt | -30 | -1,754 |
| Change in fair value of derivative financial instruments | 166 | -1,379 |
| Accounts and other receivables | -17,741 | 13,581 |
| Other assets | 887 | 5,006 |
| Accounts payable and accrued liabilities | 10,844 | 16,735 |
| Operating lease liabilities | 7,270 | 15,523 |
| Security deposits, prepaid rent and other liabilities | -1,222 | -327 |
| Net cash provided by operating activities | 107,185 | 132,091 |
| Developments and capital expenditures | 32,352 | 48,077 |
| Acquisitions of real estate investments | 258,515 | 81,886 |
| Proceeds from dispositions of real estate investments | 10,154 | 36,428 |
| Investments in unconsolidated entities | 83 | 360 |
| Issuances of real estate notes receivable | 0 | 5,855 |
| Principal repayments on real estate notes receivable | 3,000 | 6,625 |
| Real estate and other deposits | 661 | 1,737 |
| Net cash used in investing activities | -278,457 | -94,862 |
| Borrowings under mortgage loans payable | 0 | 30,000 |
| Payments on mortgage loans payable | 13,004 | 30,708 |
| Borrowings under the lines of credit and term loan | 82,500 | 132,500 |
| Payments on the lines of credit and term loan | 82,500 | 271,532 |
| Payments on financing and other obligations | 349 | 1,049 |
| Deferred financing costs | 0 | 259 |
| Debt extinguishment costs | 52 | 52 |
| Proceeds from issuance of common stock in offerings | 243,276 | 236,300 |
| Proceeds from issuance of common stock pursuant to employee stock purchase plan | 238 | - |
| Payment of offering costs | 2,424 | 2,313 |
| Distributions paid | 41,241 | 79,425 |
| Repurchase of common stock | 0 | 0 |
| Payments to taxing authorities in connection with common stock directly withheld from employees | 0 | 2,402 |
| Purchase of noncontrolling interests | 0 | 0 |
| Distributions to noncontrolling interests | 602 | 1,214 |
| Redemptions of noncontrolling interests | 0 | 0 |
| Security deposits | -151 | -498 |
| Net cash provided by financing activities | 185,691 | 9,348 |
| Net change in cash, cash equivalents and restricted cash | 14,419 | 46,577 |
| Effect of exchange rate changes on cash | 66 | - |
| Cash and cash equivalents at beginning of period | 123,301 | - |
| Cash and cash equivalents at end of period | 184,363 | - |
American Healthcare REIT, Inc. (AHR)
American Healthcare REIT, Inc. (AHR)